Stock Screener App

Frei -

Installieren

0.099

3.23% -0.0033

after-market

Handel nachbörslich: .10 0.001 +1.01%

Quince Therapeutics Inc (QNCX)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	28.80% 13.43	10.43	14.86	12.01	5.863
Depreciation and Amortization	2.86% 0.036	0.035	0.032	0.016	0.086
Operating Income/Loss	28.80% -13.43	-10.43	-14.86	-12.01	-5.863
Income/Loss From Continuing Operations Before Tax	14.96% -13.53	-15.91	-14.98	-12.45	-5.466
Income Tax Expense/Benefit	168.66% -0.046	0.067	0.047	0.007	0.013
Income/Loss From Continuing Operations After Tax	15.61% -13.49	-15.98	-15.03	-12.46	-5.479
Net Income/Loss	15.61% -13.49	-15.98	-15.03	-12.46	-5.479
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	168.66% -0.046	0.067	-	-	0.013
Basic Average Shares	15.56% 53.95	46.69	43.94	0.1716	43.16
Diluted Average Shares	15.56% 53.95	46.69	43.94	0.1716	43.16
Basic Earnings Per Share	26.47% -0.25	-0.34	-0.34	-0.28	-0.13
Diluted Earnings Per Share	26.47% -0.25	-0.34	-0.34	-0.28	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RVMD

$99.12

0.49%

ROIV

$28.33

1.76%

RPRX

$48.57

0.16%

BNTX

$91.18

1.97%

ONC

$310.79

0.76%

INSM

$162.43

1.47%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters